FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Peter Bytzer

Research Profile

Disorders

Chemicals & Drugs

Procedures

Living Beings

Helicobacter pylori

Concepts & Ideas

Geographic Areas

Denmark

Activities & Behaviors

Questionnaires

Co-author Network

Publications

TOP 3
Laura Rindom Krogsgaard; Anne Line Engsbro; Peter Bytzer
The epidemiology of irritable bowel syndrome in Denmark. A population-based survey in adults ≤50 years of age.
Anders Bergh Lødrup; Christina Reimer; Peter Bytzer
Systematic review: symptoms of rebound acid hypersecretion following proton pump inhibitor treatment.
Peter Bytzer; Stuart J Connolly; Michael Ezekowitz; Stephan Formella; Paul A Reilly; Sean Yang; James Aisenberg
Analysis of upper gastrointestinal adverse events among patients given dabigatran in the RE-LY trial.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Peter Bytzer (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Laura Rindom Krogsgaard; Anne Line Engsbro; Peter Bytzer
The epidemiology of irritable bowel syndrome in Denmark. A population-based survey in adults ≤50 years of age.
Scandinavian journal of gastroenterology 2013;48(5):523-9.
2013: Anders Bergh Lødrup; Christina Reimer; Peter Bytzer
Systematic review: symptoms of rebound acid hypersecretion following proton pump inhibitor treatment.
Scandinavian journal of gastroenterology 2013;48(5):515-22.
2013: Peter Bytzer; Stuart J Connolly; Michael Ezekowitz; Stephan Formella; Paul A Reilly; Sean Yang; James Aisenberg
Analysis of upper gastrointestinal adverse events among patients given dabigatran in the RE-LY trial.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2013;11(3):246-52.e1-5.
2013: Peter Bytzer; Eric Elkin; Jørgen Naesdal; Stephen Pratt; Elisabeth Sörstadius
Burden of upper gastrointestinal symptoms in patients receiving low-dose acetylsalicylic acid for cardiovascular risk management: a prospective observational study.
American journal of cardiovascular drugs : drugs, devices, and other interventions 2013;13(1):27-35.
2012: Anne Line Engsbro; Henrik V Nielsen; C Rune Stensvold; Peter Bytzer
Treatment of Dientamoeba fragilis in patients with irritable bowel syndrome.
The American journal of tropical medicine and hygiene 2012;87(6):1046-52.
2012: Peter Bytzer; Roger Jones; Ola Junghard; Tore Lind; Nimish Vakil; Börje Wernersson; John Dent
Limited ability of the proton-pump inhibitor test to identify patients with gastroesophageal reflux disease.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2012;10(12):1360-6.
2012: Peter Bytzer; H Mattsson; S Veldhuyzen van Zanten; B Wernersson
Partial symptom-response to proton pump inhibitors in patients with non-erosive reflux disease or reflux oesophagitis - a post hoc analysis of 5796 patients.
Alimentary pharmacology & therapeutics 2012;36(7):635-43.
2012: Christina Reimer; Peter Bytzer
[Adverse events associated with long-term use of proton pump inhibitors].
Ugeskrift for laeger 2012;174(39):2289-93.
2012: Peter Bytzer; Erik Christensen; Lars K Langkilde; Villy Meineche-Schmidt
Work productivity improvement after acid suppression in patients with uninvestigated dyspepsia.
Danish medical journal 2012;59(7):A4461.
2012: Peter Bytzer
New hope for functional dyspepsia?
Gut 2012;61(6):789-90.
2011: Per M Hellström; Stefan Mueller-Lissner; Yuri A Saito; Jan Tack; Peter Bytzer; Lin Chang
Characteristics of acute pain attacks in patients with irritable bowel syndrome meeting Rome III criteria.
The American journal of gastroenterology 2011;106(7):1299-307.
2011: Bo Søndergaard; Johan Olsson; Kajsa Ohlson; Ulla Svensson; Peter Bytzer; Rickard Ekesbo
Effects of probiotic fermented milk on symptoms and intestinal flora in patients with irritable bowel syndrome: a randomized, placebo-controlled trial.
Scandinavian journal of gastroenterology 2011;46(6):663-72.
2011: Peter Bytzer; Jens Frederik Dahlerup; Jens Ravn Eriksen; Dorte Ejg Jarbøl; Steffen Rosenstock; Signe Wildt
Diagnosis and treatment of Helicobacter pylori infection.
Danish medical bulletin 2011;58(4):C4271.
2010: Christina Reimer; Peter Bytzer
Discontinuation of long-term proton pump inhibitor therapy in primary care patients: a randomized placebo-controlled trial in patients with symptom relapse.
European journal of gastroenterology & hepatology 2010;22(10):1182-8.
2010: John Dent; Nimish Vakil; Roger Jones; Peter Bytzer; Uwe Schöning; Katarina Halling; Ola Junghard; Tore Lind
Accuracy of the diagnosis of GORD by questionnaire, physicians and a trial of proton pump inhibitor treatment: the Diamond Study.
Gut 2010;59(6):714-21.
2010: Peter Bytzer
Dyspepsia as an adverse effect of drugs.
Best practice & research. Clinical gastroenterology 2010;24(2):109-20.
2009: C Reimer; Peter Bytzer
Clinical trial: long-term use of proton pump inhibitors in primary care patients - a cross sectional analysis of 901 patients.
Alimentary pharmacology & therapeutics 2009;30(7):725-32.
2009: Peter Bytzer
What makes individuals with gastroesophageal reflux disease dissatisfied with their treatment?
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2009;7(8):816-22.
2009: Christina Reimer; Bo Søndergaard; Linda Hilsted; Peter Bytzer
Proton-pump inhibitor therapy induces acid-related symptoms in healthy volunteers after withdrawal of therapy.
Gastroenterology 2009;137(1):80-7, 87.e1.
2009: Jens Kjeldsen; Torsten Pless; Søren Meisner; Peter Bytzer
[Endoscopy in patients receiving anticoagulation or antiplatelet therapy].
Ugeskrift for laeger 2009;171(17):1384-6.
2009: Christina Reimer; Peter Bytzer
A population-based survey to assess troublesome symptoms in gastroesophageal reflux disease.
Scandinavian journal of gastroenterology 2009;44(4):394-400.
2008: J Dent; Peter J Kahrilas; Nimish Vakil; S Veldhuyzen Van Zanten; Peter Bytzer; Brendan Delaney; Ken Haruma; Jan G Hatlebakk; E McColl; Paul Moayyedi; V Stanghellini; J Tack; Michael F Vaezi
Clinical trial design in adult reflux disease: a methodological workshop.
Alimentary pharmacology & therapeutics 2008;28(1):107-26.
2008: Jan Fog Pedersen; LG Madsen; VA Larsen; Ole Hamberg; Thomas Horn; Birgitte Federspiel; Peter Bytzer
A Doppler waveform index to characterize hepatic vein velocity pattern and evaluate hepatic fibrosis.
Journal of clinical ultrasound : JCU 2008;36(4):208-11.
2008: Peter Bytzer
[Acid-related disorders].
Ugeskrift for laeger 2008;170(7):525-7.
2008: Christina Reimer; Peter Bytzer
Management of laryngopharyngeal reflux with proton pump inhibitors.
Therapeutics and clinical risk management 2008;4(1):225-33.
2008: LG Madsen; Peter Bytzer
Symptomatic response to blocked and unblocked pentagastrin stimulation in functional dyspepsia. Comparison of responders and non-responders to omeprazole identified in a single-subject trial model.
Digestive diseases (Basel, Switzerland) 2008;26(3):237-42.
2007: LG Madsen; Jane Møller Hansen; M Grønvold; Peter Bytzer
The validity of a symptom diary in ratings of dyspepsia measured against a detailed interview: do patients and clinicians agree in their assessment of symptoms?
Alimentary pharmacology & therapeutics 2007;26(6):905-12.
2007: Peter Bytzer
Information bias in endoscopic assessment.
The American journal of gastroenterology 2007;102(8):1585-7.
2007: Mark van Blankenstein; Caspar W N Looman; Michelle E Kruijshaar; Peter D Siersema; Ernst J Kuipers; Peter Bytzer
Modelling a population with Barrett's oesophagus from oesophageal adenocarcinoma incidence data.
Scandinavian journal of gastroenterology 2007;42(3):308-17.
2007: David C Metz; John M Inadomi; Colin Howden; Sander J Veldhuyzen van Zanten; Peter Bytzer
On-demand therapy for gastroesophageal reflux disease.
The American journal of gastroenterology 2007;102(3):642-53.
2007: Christina Reimer; Peter Bytzer
Perceptions and beliefs concerning gastroesophageal reflux disease: physicians and patients disagree.
Digestion 2007;76(3-4):229-34.
2006: Peter Bytzer; Anna Morocutti; Peter Kennerly; Miroslav Ravic; Neil Miller
Effect of rabeprazole and omeprazole on the onset of gastro-oesophageal reflux disease symptom relief during the first seven days of treatment.
Scandinavian journal of gastroenterology 2006;41(10):1132-40.
2006: A Krag; L S Teglbjerg; A Malchow-Møller; J Hallas; Peter Bytzer
Prescribing of acid suppressive therapy: interactions between hospital and primary care.
Alimentary pharmacology & therapeutics 2006;23(12):1713-8.
2006: Peter Bytzer
Management of the dyspeptic patient: anything goes?
The American journal of gastroenterology 2006;101(6):1209-10.
2006: Peter Bytzer
[Nobel Prize for the discovery of Helicobacter pylori. The Danish Society of Gastroenterology].
Ugeskrift for laeger 2006;168(12):1216.
2005: Peter Bytzer
[Dyspepsia and Helicobacter--from evidence to clinical practice].
Ugeskrift for laeger 2005;167(49):4631.
2005: Jane Møller Hansen; Palle Nordblad Schmidt; Peter Matzen; Hans Jørgen Gyrtrup; Peter Bytzer
[Appropriateness of colonoscopy. Are European standards applicable to a Danish population?].
Ugeskrift for laeger 2005;167(16):1738-42.
2005: Palle Nordblad Schmidt; Jane Møller Hansen; Peter Bytzer; Hans Jørgen Gyrtrup; Peter Matzen
[The quality of colonoscopy in Denmark. Results from a European quality study].
Ugeskrift for laeger 2005;167(16):1733-7.
2005: Mark van Blankenstein; Caspar W N Looman; Wim C J Hop; Peter Bytzer
The incidence of adenocarcinoma and squamous cell carcinoma of the esophagus: Barrett's esophagus makes a difference.
The American journal of gastroenterology 2005;100(4):766-74.
2005: Peter Bytzer
Gastro-oesophageal reflux disease: epidemiologic challenges.
Scandinavian journal of gastroenterology 2005;40(3):247-9.
2005: Bo Søndergaard; Peter Bytzer
[Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients].
Ugeskrift for laeger 2005;167(5):500-2.
2005: Dyfrig A Hughes; Keith Bodger; Peter Bytzer; Dirk de Herdt; Dominique Dubois
Economic analysis of on-demand maintenance therapy with proton pump inhibitors in patients with non-erosive reflux disease.
PharmacoEconomics 2005;23(10):1031-41.
2005: Peter Bytzer; Colm O'Morain
Treatment of Helicobacter pylori.
Helicobacter 2005;10 Suppl 1():40-6.
2004: Annika Berntsen; Peter Bytzer
[Treatment of hospitalized patients in a medical department with acid-suppressing medication].
Ugeskrift for laeger 2004;166(38):3294-7.
2004: LG Madsen; L Wallin; Peter Bytzer
Identifying response to acid suppressive therapy in functional dyspepsia using a random starting day trial--is gastro-oesophageal reflux important?
Alimentary pharmacology & therapeutics 2004;20(4):423-30.
2004: Peter Bytzer; A L Blum
Personal view: rationale and proposed algorithms for symptom-based proton pump inhibitor therapy for gastro-oesophageal reflux disease.
Alimentary pharmacology & therapeutics 2004;20(4):389-98.
2004: Peter Bytzer
Diagnostic approach to dyspepsia.
Best practice & research. Clinical gastroenterology 2004;18(4):681-93.
2004: LG Madsen; Peter Bytzer
Reproducibility of a symptom response to omeprazole therapy in functional dyspepsia evaluated by a random-starting-day trial design.
Alimentary pharmacology & therapeutics 2004;20(3):365-72.
2004: Peter Bytzer; A Blum; D De Herdt; Dominique Dubois
Six-month trial of on-demand rabeprazole 10 mg maintains symptom relief in patients with non-erosive reflux disease.
Alimentary pharmacology & therapeutics 2004;20(2):181-8.
2004: Peter Bytzer
Assessment of reflux symptom severity: methodological options and their attributes.
Gut 2004;53 Suppl 4():iv28-34.
2004: Mette Graversen; Peter Bytzer
[Serologic testing after needlestick incidents in hospitals. A questionnaire study].
Ugeskrift for laeger 2004;166(7):592-5.
2003: Peter Bytzer; Bo Søndergaard
[Proton pump inhibitors--are they really harmless?2].
Ugeskrift for laeger 2003;165(40):3838-9; author reply 3839.
2003: Peter Bytzer
Goals of therapy and guidelines for treatment success in symptomatic gastroesophageal reflux disease patients.
The American journal of gastroenterology 2003;98(3 Suppl):S31-9.
2003: Johann Hammer; Stuart Howell; Peter Bytzer; Michael Horowitz; Nicholas J Talley
Symptom clustering in subjects with and without diabetes mellitus: a population-based study of 15,000 Australian adults.
The American journal of gastroenterology 2003;98(2):391-8.
2002: Peter Bytzer
H(2) receptor antagonists and prokinetics in dyspepsia: a critical review.
Gut 2002;50 Suppl 4():iv58-62.
2002: Finn Møller Pedersen; Peter Vilmann; Peter Bytzer
Gastric arteriovenous malformation: Doppler EUS-guided diagnosis and therapy.
Gastrointestinal endoscopy 2002;55(4):597-9.
2002: Peter Bytzer; Nicholas J Talley; Johann Hammer; Lisa J Young; Michael P Jones; Michael Horowitz
GI symptoms in diabetes mellitus are associated with both poor glycemic control and diabetic complications.
The American journal of gastroenterology 2002;97(3):604-11.
2002: Gerald Holtmann; Peter Bytzer; M Metz; V Loeffler; André L Blum
A randomized, double-blind, comparative study of standard-dose rabeprazole and high-dose omeprazole in gastro-oesophageal reflux disease.
Alimentary pharmacology & therapeutics 2002;16(3):479-85.
2002: LG Madsen; Peter Bytzer
Review article: Single subject trials as a research instrument in gastrointestinal pharmacology.
Alimentary pharmacology & therapeutics 2002;16(2):189-96.
2001: Peter Bytzer; Nicholas J Talley; M Leemon; L J Young; Michael P Jones; Michael Horowitz
Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults.
Archives of internal medicine 2001;161(16):1989-96.
2001: Peter Bytzer; Stuart Howell; M Leemon; L J Young; Michael P Jones; Nicholas J Talley
Low socioeconomic class is a risk factor for upper and lower gastrointestinal symptoms: a population based study in 15 000 Australian adults.
Gut 2001;49(1):66-72.
2001: Peter Bytzer; Nicholas J Talley
Current indications for acid suppressants in dyspepsia.
Best practice & research. Clinical gastroenterology 2001;15(3):385-400.
2001: Peter Bytzer
On-demand therapy for gastro-oesophageal reflux disease.
European journal of gastroenterology & hepatology 2001;13 Suppl 1():S19-22.
2001: Peter Bytzer; PS Teglbjaerg
Helicobacter pylori-negative duodenal ulcers: prevalence, clinical characteristics, and prognosis--results from a randomized trial with 2-year follow-up.
The American journal of gastroenterology 2001;96(5):1409-16.
2001: S J Talley; Peter Bytzer; Johann Hammer; L Young; Michael Jones; Michael Horowitz
Psychological distress is linked to gastrointestinal symptoms in diabetes mellitus.
The American journal of gastroenterology 2001;96(4):1033-8.
2001: Nicholas J Talley; L Young; Peter Bytzer; Johann Hammer; M Leemon; Michael Jones; Michael Horowitz
Impact of chronic gastrointestinal symptoms in diabetes mellitus on health-related quality of life.
The American journal of gastroenterology 2001;96(1):71-6.
2001: Peter Bytzer; Nicholas J Talley; M P Jones; M Horowitz
Oral hypoglycaemic drugs and gastrointestinal symptoms in diabetes mellitus.
Alimentary pharmacology & therapeutics 2001;15(1):137-42.
2000: Peter Bytzer; Jane Møller Hansen; S Rune; O Bonnevie; H Breinstrup; Peter Funch-Jensen; Peter Matzen; V Meineche-Schmidt; Ove B Schaffalitzky de Muckadell
Identifying responders to acid suppression in dyspepsia using a random starting day trial.
Alimentary pharmacology & therapeutics 2000;14(11):1485-94.
2000: Peter Bytzer; J Hallas
Drug-induced symptoms of functional dyspepsia and nausea. A symmetry analysis of one million prescriptions.
Alimentary pharmacology & therapeutics 2000;14(11):1479-84.
2000: Peter Bytzer; C Aalykke; S Rune; L Weywadt; T Gjørup; J Eriksen; O Bonnevie; C Bekker; H Kromann-Andersen; J Kjaergaard; J Rask-Madsen; M Vilien; J Hansen; T Justesen; M Vyberg; PS Teglbjaerg
Eradication of Helicobacter pylori compared with long-term acid suppression in duodenal ulcer disease. A randomized trial with 2-year follow-up. The Danish Ulcer Study Group.
Scandinavian journal of gastroenterology 2000;35(10):1023-32.
2000: LG Madsen; Peter Bytzer
The value of alarm features in identifying organic causes of dyspepsia.
Canadian journal of gastroenterology = Journal canadien de gastroenterologie 2000;14(8):713-20.
2000: LG Madsen; M Taskiran; Peter Bytzer
[Menetrier's disease. Another Helicobacter pylori associated disease?].
Ugeskrift for laeger 2000;162(32):4250-3.
2000: Annmarie Lassen; Finn Møller Pedersen; Peter Bytzer; Ove B Schaffalitzky de Muckadell
Helicobacter pylori test-and-eradicate versus prompt endoscopy for management of dyspeptic patients: a randomised trial.
Lancet 2000;356(9228):455-60.
1999: Peter Bytzer
Cost-effectiveness of gastroscopy.
Italian journal of gastroenterology and hepatology 1999;31(8):749-60.
1999: LG Madsen; M Taskiran; J L Madsen; Peter Bytzer
Ménétrier's disease and Helicobacter pylori: normalization of gastrointestinal protein loss after eradication therapy.
Digestive diseases and sciences 1999;44(11):2307-12.
1999: Nicholas J Talley; A Axon; Peter Bytzer; G Holtmann; Shiu Kum Lam; Sander Veldhuyzen van Zanten
Management of uninvestigated and functional dyspepsia: a Working Party report for the World Congresses of Gastroenterology 1998.
Alimentary pharmacology & therapeutics 1999;13(9):1135-48.
1998: Jane Møller Hansen; Peter Bytzer; Ove B Schaffalitzky de Muckadell
Management of dyspeptic patients in primary care. Value of the unaided clinical diagnosis and of dyspepsia subgrouping.
Scandinavian journal of gastroenterology 1998;33(8):799-805.
1998: Jane Møller Hansen; Peter Bytzer; Ove B Schaffalitzky de Muckadell
Placebo-controlled trial of cisapride and nizatidine in unselected patients with functional dyspepsia.
The American journal of gastroenterology 1998;93(3):368-74.
1998: Jesper Hallas; Peter Bytzer
Screening for drug related dyspepsia: an analysis of prescription symmetry.
European journal of gastroenterology & hepatology 1998;10(1):27-32.
1997: Jane Møller Hansen; Jesper Hallas; Jens Martin Lauritsen; Peter Bytzer
[NSAID and ulcer complications. An analysis of risk factors].
Ugeskrift for laeger 1997;159(24):3787-91.
1997: Peter Bytzer; Jane Møller Hansen; Ove B Schaffalitzky de Muckadell; A Malchow-Møller
Predicting endoscopic diagnosis in the dyspeptic patient. The value of predictive score models.
Scandinavian journal of gastroenterology 1997;32(2):118-25.
1996: Peter Bytzer; Jane Møller Hansen; Troels Havelund; A Malchow-Møller; Ove B Schaffalitzky de Muckadell
Predicting endoscopic diagnosis in the dyspeptic patient: the value of clinical judgement.
European journal of gastroenterology & hepatology 1996;8(4):359-63.
1996: Jane Møller Hansen; Jesper Hallas; Jens Martin Lauritsen; Peter Bytzer
Non-steroidal anti-inflammatory drugs and ulcer complications: a risk factor analysis for clinical decision-making.
Scandinavian journal of gastroenterology 1996;31(2):126-30.
1995: Peter Bytzer; Jane Møller Hansen; Ove B Schaffalitzky de Muckadell
[Survey of patients with upper gastrointestinal tract dyspepsia. A trial of H2 blocker therapy or endoscopy--a randomized trial of 2 management methods].
Ugeskrift for laeger 1995;157(7):893-7.
1994: Ove B Schaffalitzky de Muckadell; Peter Bytzer
[Is the clinical classification of dyspepsia patients worth the effort?].
Ugeskrift for laeger 1994;156(15):2258-9.
1994: Peter Bytzer; Jane Møller Hansen; Ove B Schaffalitzky de Muckadell
Empirical H2-blocker therapy or prompt endoscopy in management of dyspepsia.
Lancet 1994;343(8901):811-6.
1993: Peter Bytzer; Troels Havelund; Jane Møller Hansen
Interobserver variation in the endoscopic diagnosis of reflux esophagitis.
Scandinavian journal of gastroenterology 1993;28(2):119-25.
1992: Peter Bytzer; Ove B Schaffalitzky de Muckadell
Prediction of major pathologic conditions in dyspeptic patients referred for endoscopy. A prospective validation study of a scoring system.
Scandinavian journal of gastroenterology 1992;27(11):987-92.
1991: Peter Bytzer
Endoscopic follow-up study of gastric ulcer to detect malignancy: is it worthwhile?
Scandinavian journal of gastroenterology 1991;26(11):1193-9.
1991: Jane Møller Hansen; Peter Bytzer; S Bondesen; Ove B Schaffalitzky de Muckadell
Efficacy and outcome of an open access endoscopy service.
Danish medical bulletin 1991;38(3):288-90.
1990: Peter Bytzer; M Stokholm; I Andersen; B Lund-Hansen; Ove B Schaffalitzky de Muckadell
Aetiology, medical history, and faecal weight in adult patients referred for diarrhoea. A prospective survey.
Scandinavian journal of gastroenterology 1990;25(6):572-8.
1989: Peter Bytzer; M Stokholm; I Andersen; N A Klitgaard; Ove B Schaffalitzky de Muckadell
Prevalence of surreptitious laxative abuse in patients with diarrhoea of uncertain origin: a cost benefit analysis of a screening procedure.
Gut 1989;30(10):1379-84.
1988: Karsten Lauritsen; S J Rune; H R Wulff; J H Olsen; L S Laursen; Troels Havelund; L Astrup; F Bendtsen; J Linde; Peter Bytzer
Effect of omeprazole and cimetidine on prepyloric gastric ulcer: double blind comparative trial.
Gut 1988;29(2):249-53.
1987: Karsten Lauritsen; Troels Havelund; L S Laursen; Peter Bytzer; J Kjaergaard; Jørgen Rask-Madsen
Enprostil and ranitidine in prevention of duodenal ulcer relapse: one year double blind comparative trial.
British medical journal (Clinical research ed.) 1987;294(6577):932-4.
1986: Peter Bytzer; N A Klitgaard
[Chromatographic demonstration of anthraquinone derivatives in the urine. A method of proving surreptitious laxative abuse].
Ugeskrift for laeger 1986;148(23):1390-2.
1986: Karsten Lauritsen; L S Laursen; Troels Havelund; Peter Bytzer; L B Svendsen; Jørgen Rask-Madsen
Enprostil and ranitidine in duodenal ulcer healing: double blind comparative trial.
British medical journal (Clinical research ed.) 1986;292(6524):864-6.
1985: Karsten Lauritsen; L S Laursen; Troels Havelund; Peter Bytzer; Jørgen Rask-Madsen
Controlled trial of arbaprostil in bleeding peptic ulcer.
British medical journal (Clinical research ed.) 1985;291(6502):1093.
1985: Karsten Lauritsen; S J Rune; Peter Bytzer; H Kelbaek; K G Jensen; Jørgen Rask-Madsen; F Bendtsen; J Linde; M Højlund; H H Andersen
Effect of omeprazole and cimetidine on duodenal ulcer. A double-blind comparative trial.
The New England journal of medicine 1985;312(15):958-61.